BASECARE-B (02170) announced that the board of directors has reviewed and approved a proposal to implement an H-share full circulation scheme. This involves converting approximately 191 million of the company's non-listed shares into H-shares. Subject to obtaining all necessary approvals and/or filings, including the filing notice from the China Securities Regulatory Commission and approval from The Stock Exchange of Hong Kong Limited, and compliance with all applicable laws, regulations, and rules, these non-listed shares will be converted into H-shares. The company will then apply for approval for these H-shares to be listed and traded on the Main Board of The Stock Exchange of Hong Kong Limited.